Dana E. Vergoossen
Leiden, ZH 2333ZC, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.
Journal: Journal of autoimmunity
Published: January 20, 2026
Muscle-Specific Kinase Signaling and Its Therapeutic Potential.
Journal: Muscle & nerve
Published: August 29, 2025
Removing "flavor" from pathogenic antibodies hits a therapeutic sweet spot.
Journal: Science immunology
Published: December 06, 2024
ARGX-119 is an agonist antibody for human MuSK that reverses disease relapse in a mouse model of congenital myasthenic syndrome.
Journal: Science translational medicine
Published: September 18, 2024
Agonist antibody to MuSK protects mice from MuSK myasthenia gravis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: September 17, 2024
Development and characterization of agonistic antibodies targeting the Ig-like 1 domain of MuSK.
Journal: Scientific reports
Published: January 20, 2023
Enrichment of serum IgG4 in MuSK myasthenia gravis patients.
Journal: Journal of neuroimmunology
Published: August 20, 2022
Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons.
Journal: Cell reports
Published: July 29, 2021
Timing and localization of myasthenia gravis-related gene expression.
Journal: The European journal of neuroscience
Published: March 26, 2021
Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 23, 2021
Last Updated: 09/26/2026